Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective inverse agonist at GABA-A alpha5 receptor subtype enhances cognition in rats

Sep. 13, 2002

Potent, well-tolerated PDE4 inhibitor with suitable PK profile selected for development at Merck

Sep. 13, 2002

Ezetimibe + statin effective and safe in hypercholesterolemic patients with type 2 diabetes

Sep. 13, 2002

Cardioprotective effect and mechanisms of Bay-11-7085 explored

Sep. 13, 2002

PARS (PARP) activation implicated in autoimmune islet beta-cell destruction in NOD mice

Sep. 13, 2002

Antiproliferative effects of selenomethionine in human prostate cancer cells

Sep. 13, 2002

Potential new treatment option for bladder overactivity: the NK2 antagonist M-274773

Sep. 12, 2002

Combination of PPARgamma agonist and statin improves atherosclerotic lesion regression

Sep. 12, 2002

Leo reports cyclic phosphonamide MMP inhibitors with antitumor activity

Sep. 12, 2002

New class of Lp(a)-lowering agents presented last week in Barcelona

Sep. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...